Michael L. Murray

592 total citations
29 papers, 465 citations indexed

About

Michael L. Murray is a scholar working on Molecular Biology, Pharmacology and Economics and Econometrics. According to data from OpenAlex, Michael L. Murray has authored 29 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Economics and Econometrics. Recurrent topics in Michael L. Murray's work include Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Antimicrobial agents and applications (3 papers). Michael L. Murray is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Antimicrobial agents and applications (3 papers). Michael L. Murray collaborates with scholars based in United States and Australia. Michael L. Murray's co-authors include Alison Butler, Philip Hartman, Geoffrey C. Farrell, Geoffrey C. Farrell, T Kłopotowski, Michael Murphey‐Corb, Gordon F. Reidy, Philip I. Craig, P Corréa and Williams Walana and has published in prestigious journals such as New England Journal of Medicine, Gastroenterology and Journal of Bacteriology.

In The Last Decade

Michael L. Murray

25 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael L. Murray United States	11	180	149	90	53	40	29	465
S. A. Qureshi Canada	14	131 0.7×	300 2.0×	124 1.4×	24 0.5×	32 0.8×	26	619
Armin Kern Germany	9	83 0.5×	166 1.1×	55 0.6×	13 0.2×	24 0.6×	11	453
James A. Porter United States	8	249 1.4×	79 0.5×	126 1.4×	23 0.4×	13 0.3×	14	480
Kelly Rose United States	19	301 1.7×	223 1.5×	204 2.3×	80 1.5×	39 1.0×	33	918
Genevieve Parker United States	5	356 2.0×	172 1.2×	204 2.3×	86 1.6×	33 0.8×	8	516
Pauline Hall Australia	11	116 0.6×	117 0.8×	88 1.0×	43 0.8×	15 0.4×	18	569
J P Leroux France	7	218 1.2×	110 0.7×	97 1.1×	23 0.4×	37 0.9×	7	435
Rita Barallon United Kingdom	6	218 1.2×	76 0.5×	34 0.4×	70 1.3×	29 0.7×	9	427
Srinivasa Rao Jada Singapore	11	165 0.9×	238 1.6×	306 3.4×	27 0.5×	27 0.7×	18	652
Anthony R. Grivell Australia	15	26 0.1×	391 2.6×	42 0.5×	28 0.5×	43 1.1×	27	730

Countries citing papers authored by Michael L. Murray

Since Specialization

Citations

This map shows the geographic impact of Michael L. Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael L. Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael L. Murray more than expected).

Fields of papers citing papers by Michael L. Murray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael L. Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael L. Murray. The network helps show where Michael L. Murray may publish in the future.

Co-authorship network of co-authors of Michael L. Murray

This figure shows the co-authorship network connecting the top 25 collaborators of Michael L. Murray. A scholar is included among the top collaborators of Michael L. Murray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael L. Murray. Michael L. Murray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Butler, Alison, et al.. (1997). Role of CYP3A4 in Human Hepatic Diltiazem N-Demethylation: Inhibition of CYP3A4 Activity by Oxidized Diltiazem Metabolites. Journal of Pharmacology and Experimental Therapeutics. 282(1). 294–300. 110 indexed citations

Goodwin, Bryan, et al.. (1996). Effects of metyrapone on expression of CYPs 2C11, 3A2, and other 3A genes in rat hepatocytes cultured on matrigel. Biochemical Pharmacology. 52(2). 219–227. 9 indexed citations

Butler, Alison, et al.. (1995). Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor α. Gastroenterology. 109(1). 198–205. 47 indexed citations

Craig, Philip I., Michael L. Murray, & Geoffrey C. Farrell. (1992). Interferon suppresses the isoform-specific activities of hepatic cytochrome P450 in female rats. Biochemical Pharmacology. 43(4). 908–910. 14 indexed citations

Murray, Michael L. & Gordon F. Reidy. (1989). In vitro inhibition of hepatic drug oxidation by thioridazine. Biochemical Pharmacology. 38(24). 4359–4365. 10 indexed citations

Murray, Michael L.. (1987). Presidential Address: American Risk and Insurance Association August 1987: Pride in the Ties That Bind. Journal of Risk & Insurance. 54(4). 653–653. 1 indexed citations

Murray, Michael L., et al.. (1986). Another look at implied tax rates. Journal of Banking & Finance. 10(1). 133–141. 2 indexed citations

Farrell, Geoffrey C., et al.. (1985). Halothane Hepatitis. New England Journal of Medicine. 313(21). 1310–1314. 63 indexed citations

Klugman, Stuart A. & Michael L. Murray. (1984). Bodily Injury Claim Payments as a Function of Automobile Liability Insurance Limits. Journal of Risk & Insurance. 51(3). 412–412. 1 indexed citations

10.

Murray, Michael L., et al.. (1981). Mutagenic potential of residual monomers in dental resins. Journal of Dental Research. 60. 6 indexed citations

11.

Murray, Michael L.. (1979). Substrate‐specificity of uvr excision repair. Environmental Mutagenesis. 1(4). 347–352. 17 indexed citations

12.

Greene, Mark R. & Michael L. Murray. (1978). Self-Insurance of State-Owned Property. Journal of Risk & Insurance. 45(1). 109–109. 2 indexed citations

13.

Murray, Michael L., et al.. (1978). Restriction Enzyme Analysis of Plasmids from Haemophilus influenzae. Antimicrobial Agents and Chemotherapy. 13(5). 802–808. 4 indexed citations

14.

Murray, Michael L., et al.. (1978). Mutagenic Properties of Nitrosated Spermidine. Experimental Biology and Medicine. 158(1). 85–88. 13 indexed citations

15.

Murray, Michael L., et al.. (1977). Plasmid-borne resistance to erythromycin and lincomycin inStreptococcus faecalis. FEMS Microbiology Letters. 1(6). 351–355. 1 indexed citations

16.

Murray, Michael L., et al.. (1977). Occurrence of cryptic plasmids inHemophilus influenzae. FEMS Microbiology Letters. 1(5). 239–241. 5 indexed citations

17.

Murray, Michael L.. (1976). Analyzing the Investment Value of Cash Value Life Insurance. Journal of Risk & Insurance. 43(1). 121–121. 7 indexed citations

18.

Murray, Michael L., et al.. (1973). Economics and Insurance. Journal of Risk & Insurance. 40(3). 449–449. 5 indexed citations

19.

Murray, Michael L.. (1972). Empirical Utility Functions and Insurance Consumption Decisions. Journal of Risk & Insurance. 39(1). 31–31. 9 indexed citations

20.

Murray, Michael L.. (1971). A Deductible Selection Model. Development and Application. Journal of Risk & Insurance. 38(3). 423–423. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact